The effect of pimecrolimus on innate immunity in atopic dermatitis subjects: a double-blind, randomized, vehicle-controlled study

British Journal of Dermatology, 05/15/2012

Atopic dermatitis (AD) subjects respond to inflammation with lower amounts of the antimicrobial peptides (AMPs) cathelicidin (LL–37) and human beta defensin (HBD)–3.

Go to Abstract Print Article Summary